Endomag renews five-year manufacturing agreement with ITL Group

Global pioneer in improving breast cancer surgery, Endomag, has renewed a five-year manufacturing contract with ITL Group (a G&H company) for on-going production of its commercially successful surgical guidance system, the Sentimag® platform.

The Sentimag® platform helps surgeons to mark, detect and accurately remove tumours or lymph nodes causing minimal damage to the breast tissue. The technology works like a metal detector, which when placed near the skin’s surface can detect Endomag’s magnetic seed (Magseed®) or magnetic lymph node tracer (Magtrace®).

ITL Group successfully supported Endomag as it took the device from a proof of principle instrument to state-of-the-art medical technology. Endomag has won several awards for the design and production of the Sentimag® platform, including the Queen’s Award for Enterprise in Innovation in 2018.

Endomag CEO, Eric Mayes commented:

“I am delighted to continue our relationship with the team at ITL. Their expertise in design, tooling and manufacture has helped fulfil our technology’s potential as we strive to make cancer care better for patients everywhere. I am looking forward to continuing to work together, as we grow to meet global demand for the Sentimag® system.”

ITL manufactures the platform in Britain for use all around the world. To this day the Sentimag® system is the world’s most sensitive handheld magnetic probe, used in over 60,000 breast cancer procedures at over 400 hospitals in more than 30 countries.

Tom Cole, ITL Managing Director said:

“From humble beginnings as a spin-out from UCL, to now being one of ITL’s longest-standing customers, it has been an absolute pleasure to work alongside Eric and the team as they’ve grown from strength to strength. We’re delighted to secure another five years manufacturing with Endomag. They are a fantastic company to work alongside and we greatly value the opportunity to work with them longer term as they strive to improve the global standard of cancer care.”

Here’s how ITL took the SentiMag® system from concept to volume manufacture, click here.

How can we help support your next project? Get in touch.

You may also like...

News
ITL Group achieves double ISO 13485:2016 recertification

Global contract design and manufacturing partner, ITL Group (a G&H company) receives ISO 13485:2016 recertification for its Quality Management System (QMS) throughout its UK and US operations following a review by the British Standards Institute (BSI).

Read more >

Resource
Applying a regulatory approach – a guide for medical device startups

To ensure product quality and patient safety, medical device manufacturers must adhere to specific regulatory requirements and comply with rigorous safety standards. Are you aware of the regulatory approach necessary to compliantly manage your device from concept through to commercialisation?

Read more >

Case Study
Magnasense

From lab based analysis to mobile and disposable ‘point of care testing’ (POCT)

View this case study >